Medical Writing Global Market Report 2024

The medical writing market size has grown rapidly in recent years. It will grow from $3.42 billion in 2023 to $3.81 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed in the historic period can be attributed to several key factors, including the escalation of pharmaceutical research and development (R&D), the growing complexity of drugs and therapies, an increasing demand for regulatory writing, the necessity for accurate and compliant scientific documentation, and the expansion of clinical trials. These factors collectively contributed to the advancement and expansion of the medical writing field during the historical period.

The medical writing market size is expected to see rapid growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be linked to several factors, including the ongoing digital transformation in healthcare, a rising trend of remote work and virtual collaboration in the field of medical writing, the integration of patient input into medical writing processes, the emergence of personalized medicine, an uptick in the outsourcing of clinical research, a shift towards patient-centric communication, and the incorporation of real-world data into publications. Major trends expected in the forecast period encompass technological advancements, an increasing utilization of artificial intelligence and machine learning in medical writing, collaborative partnerships between medical writing agencies, technology providers, and pharmaceutical companies, as well as advancements in digital tools and platforms that have streamlined and enhanced the efficiency of medical writing processes.

The anticipated growth in the medical writing market is expected to be propelled by the increasing development of new drugs. Novel drugs, defined as pharmaceutical substances not previously approved or marketed for therapeutic use, are a focal point in pharmaceutical advancements. Medical writing contributes significantly to the development of new drugs by providing essential strategies and techniques for the creation of documents necessary in the drug development process. This includes the publication of information related to drug research and information technology. For example, a report published by the Food and Drug Administration in January 2023 revealed that the Center for Drug Evaluation and Research (CDER) granted approval to 37 new drugs in 2022, categorized as novel drugs, indicating substances that had not been previously approved or marketed in the United States. Among these, 20 drugs, accounting for 54%, received approval during the same year. Consequently, the rising development of new drugs is a key driver for the growth of the medical writing market.

The surge in the number of clinical trials is expected to contribute to the growth of the medical writing market. Clinical trials, carefully designed and conducted research studies involving human participants to assess the safety, efficacy, and potential side effects of medical interventions, are on the rise. Medical writing plays a crucial role in all stages of clinical trials, ensuring clear, accurate, and concise communication throughout the research process. This impact extends across various facets of the trial, from planning to publication. As of May 2023, a report by Xtalks indicated that there were 452,604 clinical studies registered on ClinicalTrials.gov, marking a substantial increase from the over 365,000 registered trials recorded in early 2021. Therefore, the upward trend in the number of clinical trials is a significant driver for the growth of the medical writing market.

Product innovation has emerged as a prominent trend in the medical writing market, with major companies strategically focusing on creating innovative solutions to enhance their market positions. One notable example is Certara Inc., a US-based company specializing in drug development software and services. In September 2021, Certara Inc. introduced the New Synchrogenix Writer Software, which automates data mapping and facilitates early writing before database lock. This innovation aims to improve consistency, reduce risk, and expedite the regulatory filing process. The software also includes a regulatory Software as a Service (SaaS) application designed to accelerate the production and evaluation of patient narratives, crucial for clinical research reporting across therapeutic areas and clinical phases.

Major players in the medical writing market are leveraging advanced technologies, such as AI-based medical writing software, to cater to a broader customer base, drive sales, and increase revenue. An example is Certara, Inc.'s launch of CoAuthor in October 2023. CoAuthor is an AI-based system that provides comprehensive support to medical writers, expediting the development of various clinical trial documents, including protocols, synopses, clinical study reports (CSRs), and patient narratives. The platform facilitates seamless integration of analysis datasets, CDISC data, tables, listings, and figures directly into reports, offering real-time previews and enabling content refresh as needed. CoAuthor establishes a digital data flow, ensuring consistency and saving time through content reuse. Notably, the auto-generated content feature allows writers to choose eTemplates from the library, automatically populating content, headings, styles, and more.

In July 2021, ICON PLC, an Ireland-based clinical research organization, acquired PRA Health Science Inc for an undisclosed amount. This strategic acquisition aimed to enhance operations, transform clinical trials, and accelerate the commercial success of biopharma clients by addressing the urgent need for pharmaceuticals and medical devices. PRA Health Sciences Inc., based in the US, is a contract research organization (CRO) providing services such as data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting.

Major companies operating in the medical writing market report are Cardinal Health Inc., Merck and Co. Inc., AbbVie Inc., Abbott Laboratories, Medtronic Plc., Labcorp Drug Development Inc., IQVIA Holdings Inc., Icon Plc., Parexel International Corporation, Syneos Health, Ashfield Healthcare Limited, Indegene Pvt. Ltd., UDG Healthcare Plc., Evidera, Certara Inc., MMS Holdings Inc., Freyr Solutions, Cactus Communication Ltd., Omics International Pvt Ltd., Quanticate International limited, Inclin Inc., Criterium Inc., Aptitude Health., Siro Clinpharm Private Limited, ProScribe Medical Communications, Pegasus Knowledge Solutions Inc., Cognibrain, Scientific Communications Group, InkLab Medical Communications, Trilogy Writing and Consulting GmbH.

North America was the largest region in the medical writing market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the medical writing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical writing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

There are several main types of medical writing, including clinical writing, regulatory writing, scientific writing, and others. Clinical writing is a distinct category within medical writing that encompasses various materials regularly used by healthcare professionals. This includes writing found in research-based documents, scientific papers, journal abstracts, and manuscripts. Clinical writing plays a crucial role in medical journalism, medical education, medico marketing, and other contexts, with pharmaceutical companies, contract research organizations (CROs), and other entities utilizing these written materials.

The medical writing research report is one of a series of new reports that provides medical writing market statistics, including the medical writing industry's global market size, regional shares, competitors with medical writing market share, detailed medical writing market segments, market trends and opportunities, and any further data you may need to thrive in the medical writing industry. This medical writing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical writing market includes revenues earned by entities by providing services such as consumer health writing, clinical trial reports, social media writing, healthcare marketing materials, patient education materials, scientific posters, and presentations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.